TLR4 and Parkinson disease: Ren et al. revealed that TREM2 has the potential to impede the TRAF6/TLR4-induced activation of both MAPK and NF-κB pathways, which could account for its protective effects against neuroinflammation and DA cell destruction in the MPTP mouse model of PD [121].